Literature DB >> 14522851

Prion propagation in cultured cells.

Jérôme Solassol1, Carole Crozet, Sylvain Lehmann.   

Abstract

Cell cultures represent relevant and useful experimental models of transmissible spongiform encephalopathies (TSEs). They are able to promote, upon subpassaging, stable and persistent replication of PrP(Sc) as well as infectivity. To date, only a few cell culture models permissive to prion replication are available. Among them, mouse neuroblastoma cell lines (N2a) are most commonly used. While they correspond to homologous models supporting propagation of mouse-adapted scrapie strains, recent studies have reported heterologous models sensitive to natural occurring disease. Infected cell culture models have provided some valuable insights into the biogenesis of PrP(Sc) in terms of conversion, subcellular localisations, physiopathological consequences and species-barrier determinants. They have also contributed to the screening and the study of possible therapeutic compounds and to the development of new strategies for the investigation of TSE-specific diagnostic markers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522851     DOI: 10.1093/bmb/66.1.87

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  24 in total

1.  Conformational transformation and selection of synthetic prion strains.

Authors:  Sina Ghaemmaghami; Joel C Watts; Hoang-Oanh Nguyen; Shigenari Hayashi; Stephen J DeArmond; Stanley B Prusiner
Journal:  J Mol Biol       Date:  2011-08-04       Impact factor: 5.469

2.  Cell division modulates prion accumulation in cultured cells.

Authors:  Sina Ghaemmaghami; Puay-Wah Phuan; Beth Perkins; Julie Ullman; Barnaby C H May; Fred E Cohen; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-07       Impact factor: 11.205

3.  PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells.

Authors:  Sophie Paquet; Nathalie Daude; Marie-Pierre Courageot; Jérôme Chapuis; Hubert Laude; Didier Vilette
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

4.  A specific population of abnormal prion protein aggregates is preferentially taken up by cells and disaggregated in a strain-dependent manner.

Authors:  Young Pyo Choi; Suzette A Priola
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

5.  CRBL cells: establishment, characterization and susceptibility to prion infection.

Authors:  Charles E Mays; Hae-Eun Kang; Younghwan Kim; Sung Han Shim; Ji-Eun Bang; Hee-Jong Woo; Youl-Hee Cho; Jae-Beom Kim; Chongsuk Ryou
Journal:  Brain Res       Date:  2008-03-18       Impact factor: 3.252

6.  Inoculation of scrapie with the self-assembling RADA-peptide disrupts prion accumulation and extends hamster survival.

Authors:  Robert Hnasko; Cathrin E Bruederle
Journal:  PLoS One       Date:  2009-02-12       Impact factor: 3.240

7.  Prion infection of epithelial Rov cells is a polarized event.

Authors:  Sophie Paquet; Elifsu Sabuncu; Jean-Louis Delaunay; Hubert Laude; Didier Vilette
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  Inhibition of PrP(Sc) formation in scrapie infected N2a cells by 5,7,8-trimethyl-3,4-dihydro-2H-1,4-benzoxazine derivatives.

Authors:  Fani Koukouli; Ioannis Paspaltsis; Evgenia Salta; Konstantinos Xanthopoulos; Eftychia N Koini; Theodora Calogeropoulou; Theodoros Sklaviadis
Journal:  Prion       Date:  2012-08-23       Impact factor: 3.931

9.  A versatile prion replication assay in organotypic brain slices.

Authors:  Jeppe Falsig; Christian Julius; Ilan Margalith; Petra Schwarz; Frank L Heppner; Adriano Aguzzi
Journal:  Nat Neurosci       Date:  2007-12-09       Impact factor: 24.884

10.  Prion strain- and species-dependent effects of antiprion molecules in primary neuronal cultures.

Authors:  Sabrina Cronier; Vincent Beringue; Anne Bellon; Jean-Michel Peyrin; Hubert Laude
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.